After StartUp Health and Rock Health, we have CB Insights releasing its digital health figures. According to them, digital health financing reached $5.8 billion in 2015, representing a small increase from the year before. The big difference has something to do with the way different firms do the math — for one thing Rock only counts deals that are worth more than $2 million.

Anyhow, CB Insight has found that there were 20 percent more deals in 2015 than in 2014, with deal count breaking the 900 mark. All this money was provided by more than 1,000 entities which made an equity investment in at least 1 digital health company, up more than a 350% from the 234 that invested in digital health in 2010.

The research firm has also found that the spike in seed deals have slowed down, with deal share hovering around 36% in the last two years. The other rounds have remained relatively range-bound based on deal share.

The top deals included Guahao, Zocdoc, and 23andMe, each of which was valued at more than $100 million. On the other hand, the most active investors were accelerators like Y Combinator and Techstars, corporate tech ventures like Qualcomm Ventures and Google Ventures, corporates from other sectors like Merck and GE, and venture capital firms like Norwest Venture Partners and Lux Capital.